Literature DB >> 14767993

Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease.

Shiqi Yang1, Ayman Koteish, Huizhi Lin, Jiawen Huang, Tania Roskams, Valina Dawson, Anna Mae Diehl.   

Abstract

Hepatic steatosis may have a generally benign prognosis, either because most hepatocytes are not significantly injured or mechanisms to replace damaged hepatocytes are induced. To determine the relative importance of these mechanisms, we compared hepatocyte damage and replication in ethanol-fed and ob/ob mice with very indolent fatty liver disease to that of healthy control mice and PARP-1(-/-) mice with targeted disruption of the DNA repair enzyme, poly(ADP-ribose) polymerase. Compared to the healthy controls, both groups with fatty livers had significantly higher serum alanine aminotransferase values, hepatic mitochondrial H(2)O(2) production, and hepatocyte oxidative DNA damage. A significantly smaller proportion of the hepatocytes from fatty livers entered S phase when cultured with mitogens. Moreover, this replicative senescence was not reversed by treating cultured hepatocytes with agents (i.e., betaine or leptin) that improve liver disease in intact ethanol-fed or leptin-deficient mice. Hepatocytes from PARP1(-/-) mice also had more DNA damage and reduced DNA synthesis in response to mitogens. However, neither mice with fatty livers nor PARP-1-deficient mice had atrophic livers. All of the mice with senescent mature hepatocytes exhibited hepatic accumulation of liver progenitor (oval) cells and oval cell numbers increased with the demand for hepatocyte replacement. Therefore, although hepatic oxidant production and damage are generally increased in fatty livers, expansion of hepatic progenitor cell populations helps to compensate for the increased turnover of damaged mature hepatocytes. In conclusion, these results demonstrate that induction of mechanisms to replace damaged hepatocytes is important for limiting the progression of fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14767993     DOI: 10.1002/hep.20082

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  49 in total

1.  Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population.

Authors:  Lu Wang; Yijin Wang; Shuhong Liu; Xiangwei Zhai; Guangde Zhou; Fengmin Lu; Jingmin Zhao
Journal:  J Gastroenterol       Date:  2019-05-27       Impact factor: 7.527

2.  Stage-specific regulation of adhesion molecule expression segregates epithelial stem/progenitor cells in fetal and adult human livers.

Authors:  Mari Inada; Daniel Benten; Kang Cheng; Brigid Joseph; Ekaterine Berishvili; Sunil Badve; Lennart Logdberg; Mariana Dabeva; Sanjeev Gupta
Journal:  Hepatol Int       Date:  2007-11-27       Impact factor: 6.047

Review 3.  Liver cancer: the role of stem cells.

Authors:  M R Alison; M J Lovell
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

4.  Hedgehog signaling influences gender-specific response of liver to radiation in mice.

Authors:  Sihyung Wang; Keumju Lee; Jeongeun Hyun; Youngjae Lee; Younghwa Kim; Youngmi Jung
Journal:  Hepatol Int       Date:  2013-07-27       Impact factor: 6.047

5.  Negligible Oval Cell Proliferation Following Ischemia-Reperfusion Injury With and Without Partial Hepatectomy.

Authors:  Ek Khoon Tan; Maureen Shuh; Heather Francois-Vaughan; Jennifer A Sanders; Ari J Cohen
Journal:  Ochsner J       Date:  2017

6.  Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver.

Authors:  Tung-Ching Ho; Er-Yea Wang; Kun-Huei Yeh; Yung-Ming Jeng; Jau-Hau Horng; Li-Ling Wu; Yi-Tzu Chen; Hsuan-Cheng Huang; Chia-Lang Hsu; Pei-Jer Chen; Shiou-Hwei Yeh; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-05       Impact factor: 11.205

Review 7.  Hepatic stem cell niches.

Authors:  Claus Kordes; Dieter Häussinger
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

8.  Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Authors:  Kerstin Abshagen; Franziska Mertens; Christian Eipel; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

9.  Cellular senescence in livers from children with end stage liver disease.

Authors:  Gabriela Gutierrez-Reyes; Maria del Carmen Garcia de Leon; Gustavo Varela-Fascinetto; Pedro Valencia; Ruy Pérez Tamayo; Claudia Gonzalez Rosado; Blanca Farfan Labonne; Norma Morales Rochilin; Rosalinda Martinez Garcia; Jonathan Aguirre Valadez; Gabriela Togno Latour; Dana Lau Corona; Guillermo Robles Diaz; Albert Zlotnik; David Kershenobich
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

Review 10.  Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Vanessa Teaberry; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.